Truion GmbH: Award winner 2023/24
"Start-up" category
With the innovation "CatFlux" the Truion GmbH from Münster has developed a completely new procedure for reproductive medicine. It is a CE-marked in-vitro diagnostic that helps doctors to optimise the chances of success of fertility treatment. Truion GmbH originated from a working group in reproductive physiology at Münster University Hospital. "CatFlux", the first diagnostic CatSper test, has only been available for just over a year.
For its sensational development, Truion GmbH received the Münsterland 2023/24 Innovation Award in the "Start-up" category.